Order Article Reprints

Neuhaus O, Köhler W, Then Bergh F, Kristoferitsch W, Faiss J, Rosenkranz T, Reske D, Patejdl R, Hartung H-P, Zettl UK. Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers. Biomolecules. 2021; 11(3):393. https://doi.org/10.3390/biom11030393

Neuhaus, Oliver, Wolfgang Köhler, Florian Then Bergh, Wolfgang Kristoferitsch, Jürgen Faiss, Thorsten Rosenkranz, Dirk Reske, Robert Patejdl, Hans-Peter Hartung, and Uwe K. Zettl. 2021. "Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers" Biomolecules 11, no. 3: 393. https://doi.org/10.3390/biom11030393

Neuhaus, O., Köhler, W., Then Bergh, F., Kristoferitsch, W., Faiss, J., Rosenkranz, T., Reske, D., Patejdl, R., Hartung, H.-P., & Zettl, U. K. (2021). Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers. Biomolecules, 11(3), 393. https://doi.org/10.3390/biom11030393